NASDAQ:EXEL Possible Scenario: LONG Evidence: Price Action TP1 ~ 24.70 This is my idea and could be wrong 100%.
NASDAQ:EXEL Possible Scenario: LONG Evidence: Price Action This is my idea and could be wrong100%
$EXEL run %54 so far on this month. It is very close to pivot. Expect to pull back to form the handle
EXEL being rejected at resistance and at the 50-day moving average. Looks primed for a reversal lower. Short opportunity
EXEL price touched strong weekly support line and going up with trendline. possibly will go long. wait for 123 pattern for confirmation. I also watching this one.
Nice volume on Friday, recent breakout after 2 months of consolidation, BBs expanding.
EXEL will bounce back with the markets starting from today.
EXEL seems breaking down from a Triangle formation in short frame & breaking down an upward channel in the long frame. We think if it breaks below $25.93, it will continue its down move to 20 or lower. To play this we would consider $27 April Puts * Trade Criteria * Date First Found- February 27, 2018 Pattern/Why- Upward channel breakdown short Entry...
There is a nice symmetrical triangle pattern that has formed just in time for earnings. A good indication that a decent move is in store for EXEL depending on the ER. Green box : gap down here into support we could see some buying off the lower trendline and 100 day SMA, or the 200 day SMA if the price gaps that far. The latter being a much stronger area to...
Here, I'm looking to sell a touch of premium in an underlying that has both high implied volatility rank (99.6%) and high background implied volatility (99.2%). Metrics: Probability of Profit: 70% Max Profit: $85/contract Buying Power Effect: Varies by Broker.* Break Even: 10.15 Notes: I'll shoot to take this off at 50% max profit. However, I could also see...
Shares of DSKX continues to rally from last week after they held a conference call to discuss the recently announced agreement to acquire Radiancy, Inc., a leading developer of consumer medical devices and the Neova® dermatological products. It appears investors are beginning to notice the financial value this new deal brings and the future outlook of the company,...